Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.53 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 1/20 | 0.53 |
| ▸ | CA7 | P43166 | 1/20 | 0.53 |
| ▸ | CA9 | Q16790 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 5/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.45 |
| ▸ | POLB | P06746 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.45 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.45 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5208927 | 0.94 | CA12 (0.49) | CA12CA1CA2CA7CA9 | |
| SCHEMBL19392375 | 0.94 | CA12 (0.49) | CA12CA1CA2CA7CA9 | |
| SCHEMBL8737479 | 0.89 | NPC1 (0.49) | CA12CA1CA2CA7CA9 | |
| 1,4-Diallyloxybenzene SCHEMBL302448 | 0.88 | CA12 (0.63) | CA12CA1CA2CA7CA9 | |
| SCHEMBL19392451 | 0.86 | CA12 (0.63) | CA12CA1CA2CA7CA9 | |
| SCHEMBL7792604 | 0.86 | NPC1 (0.57) | CA12CA1CA2CA7CA9 | |
| SCHEMBL7792609 | 0.86 | NPC1 (0.57) | CA12CA1CA2CA7CA9 | |
| SCHEMBL7860053 | 0.86 | CA12 (0.42) | CA12CA1CA2CA7CA9 | |
| SCHEMBL13581608 | 0.85 | HPGD (0.43) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9235958 | 0.84 | CA12 (0.41) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 269 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230088454-A1 | FLOOR FINISHING COMPOSITIONS WITH ENHANCED DURABILITY, METHODS OF MAKING AND USING THEREOF | DIVERSEY, INC. | 2023-03-23 | — | — | US | claimed |
| CN-113024776-B | Heat-sensitive epoxy curing agent, preparation method thereof and epoxy resin composition | 万华化学集团股份有限公司 | 2022-08-05 | — | — | CN | claimed |
| CN-113045934-A | Printing ink, application thereof and preparation method of quantum dot film | TCL集团股份有限公司 | 2021-06-29 | — | — | CN | claimed |
| CN-113024776-A | Heat-sensitive epoxy curing agent, preparation method thereof and epoxy resin composition | 万华化学集团股份有限公司 | 2021-06-25 | — | — | CN | claimed |
| US-10259928-B2 | Silane group-containing polymer composition and coatings containing same | OMNOVA SOLUTIONS INC. (US) | 2019-04-16 | — | — | US | claimed |
| EP-2804243-B1 | BINDER RESIN COMPOSITION FOR SECONDARY BATTERY ELECTRODES, SLURRY FOR SECONDARY BATTERY ELECTRODES, ELECTRODE FOR SECONDARY BATTERIES, AND LITHIUM ION SECONDARY BATTERY | MITSUBISHI CHEM CORP (JP) | 2017-10-25 | — | — | EP | claimed |
| US-9480636-B2 | Skin lightening formulations | ROHM AND HAAS COMPANY (US) | 2016-11-01 | — | — | US | claimed |
| US-7049388-B2 | Process for manufacturing an α-dihydroxy derivative and epoxy resins prepared therefrom | DOW GLOBAL TECHNOLOGIES INC. (US) | 2006-05-23 | — | — | US | claimed |
| EP-0960919-B1 | Coating bituminous substrates | ROHM & HAAS (US) | 2005-10-26 | — | — | EP | claimed |
| US-6646102-B2 | Epoxidizing an alpha - halohydrin intermediate produced from a halide substitution of an alpha -dihydroxy derivative which has been obtained by a dihydroxylation reaction of an aryl allyl ether, oxidation catalysts | DOW GLOBAL TECHNOLOGIES INC. | 2003-11-11 | — | — | US | claimed |
| US-20030105268-A1 | Process for manufacturing an alpha-dihydroxy derivative and epoxy resins prepared therefrom | DOW GLOBAL TECHNOLOGIES INC. | 2003-06-05 | — | — | US | claimed |
| US-6528581-B1 | Roof mastic coating system; improved adhesion and resistance to blistering; copolymer of alkyl acrylate, a vinyl aromatic monomer acrylic or methacrylic acid | ROHM AND HAAS COMPANY | 2003-03-04 | — | — | US | claimed |
| EP-0960919-A1 | Coating bituminous substrates | ROHM AND HAAS COMPANY (US) | 1999-12-01 | — | — | EP | claimed |
| US-5380654-A | Process for the preparation of epoxides of means of microorganisms | JAPAN ENERGY CORPORATION (JP) | 1995-01-10 | — | — | US | claimed |
| US-5376539-A | Aerobic incubation of allyl phenyl ether with arthrobacter, brevibacterium, corynebacterium, pseudomonas or rhodococcus yields glycidyl phenyl ether | NIPPON MINING CO., LTD. (JP) | 1994-12-27 | — | — | US | claimed |
| US-20260125495-A1 | CURABLE COMPOSITION, CURED BODY, OPTICAL ARTICLE, LENS AND EYE GLASSES | TOKUYAMA CORPORATION (JP) | 2026-05-07 | — | — | US | disclosed |
| EP-4660209-A1 | RESIN COMPOSITION, CURABLE COMPOSITION, CURED BODY, OPTICAL ARTICLE, RUBBER SHEET, EYE PROTECTION ARTICLE, AND ANTI-BACTERIAL/ANTI-VIRUS AGENT | TOKUYAMA CORPORATION (JP) | 2025-12-10 | — | — | EP | disclosed |
| EP-0015346-A1 | Catalyst compositions and their use in the preparation of release coatings | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1980-09-17 | — | — | EP | disclosed |
| EP-0011712-A2 | Preparation of benzaldehyde dialkyl acetals substituted in the 4-position | BASF Aktiengesellschaft (DE) | 1980-06-11 | — | — | EP | disclosed |
| US-4173592-A | MALEIMIDE ANILINE-PHENOL-FORMALDEHYDE CONDENSATE, POLYALLYLPHENYL ETHER OR POLYALLYLPHENOLIC COMPOUND | TOKYO SHIBAURA ELECTRIC CO., LTD. (JP) | 1979-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125495-A1 | CURABLE COMPOSITION, CURED BODY, OPTICAL ARTICLE, LENS AND EYE GLASSES | UACA, CRYAA, CRYAB | CA12 313/4885CA1 39/4885CA2 213/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.